NASDAQ:INO - Inovio Pharmaceuticals, Inc.
$2.82
 $0.03
+1.08%
4:00PM EDT
2019-07-22
Inovio Pharmaceuticals, Inc. (Inovio) is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  INO     avg for
industry  
  avg for
sector  
42 stocks weight:  19. 61   0. 00   0. 00  
42 stocks rank:  3. 35 K 1. 35 K 799. 74  
# analyst opinions:  8. 00   12. 76   13. 14  
mean recommendation:  1. 60   2. 11   2. 07  

quick ratio:  4. 82   5. 61   1. 85  
current ratio:  4. 92   6. 00   2. 31  

target price low:  3. 10   75. 88   108. 31  
target price avg:  4. 14   97. 27   130. 10  
target price high:  7. 00   124. 58   149. 02  
1-yr high:  6. 11   104. 89   135. 09  
last close:  2. 82   79. 79   118. 76  
50-day avg:  2. 89   79. 39   116. 18  
200-day avg:  4. 08   81. 61   114. 52  
1-yr low:  2. 29   62. 76   94. 70  
volume:  743. 98 K 2. 99 M 4. 43 M
50-day avg volume:  1. 12 M 3. 39 M 4. 22 M
200-day avg volume:  1. 11 M 3. 13 M 4. 83 M

1-day return:  1. 08 % 0. 33 % 0. 14 %
this week return:  1. 08 % 0. 33 % 0. 14 %
12-wk return:  -27. 51 % 1. 00 % 3. 51 %
52-wk return:  -33. 18 % 0. 58 % 10. 25 %

enterprise value (EV):  233. 02 M 44. 78 B 115. 63 B
market cap:  273. 51 M 38. 01 B 103. 29 B
EBITDA:  -84. 99 M 4. 47 B 7. 73 B
enterprise multiple (EV/EBITDA):  -2. 74   2. 11   11. 26  
enterprise/revenue (EV/R):  7. 33   61. 53   10. 40  
total revenue:  31. 78 M 10. 43 B 31. 15 B
total debt:  84. 44 M 11. 72 B 16. 76 B
debt/equity:  104. 29   61. 22   124. 43  
net income (common):  -93. 84 M 2. 06 B 3. 79 B

shares outstanding:  98. 03 M 562. 08 M 1. 27 B
shares:  94. 31 M 573. 33 M 1. 26 B
shares short:  11. 74 M 11. 60 M 12. 29 M
shares short prior month:  13. 73 M 9. 81 M 12. 46 M
short ratio:  7. 70   5. 88   3. 41  
short % of float:  12. 75 % 6. 88 % 2. 72 %
total cash/share:  1. 31   10. 62   8. 83  
total cash:  128. 00 M 6. 17 B 5. 72 B
free cash flow:  -64. 42 M 3. 08 B 3. 10 B
operating cash flow:  -93. 43 M 3. 99 B 4. 08 B

book value:  0. 80   12. 74   26. 25  
price/book:  3. 54   4. 38   9. 01  
gross profits:  -64. 78 M 7. 93 B 35. 64 B
operating margins:  -282. 80 % -319. 65 % -29. 05 %
EBITDA margins:  -267. 41 % 11. 82 % 24. 13 %
profit margins:  -295. 25 % 5. 62 % 14. 29 %
gross margins:  -199. 13 % 34. 75 % 57. 07 %

1-yr max volatility:  21. 01 % --- ---
1-yr mean volatility:  2. 69 % 1. 95 % 1. 25 %

1-yr EPS:  -1. 00   1. 58   3. 82  
forward EPS:  -0. 97   3. 16   6. 65  
P/E:  -2. 83   0. 21   31. 97  
forward P/E:  -2. 88   4. 95   15. 14  
PE/G:  -0. 03   0. 74   0. 13  
growth:  85. 00 % 295. 81 % 85. 47 %
earnings high:  -0. 07   0. 84   1. 56  
earnings avg:  -0. 24   0. 65   1. 45  
earnings low:  -0. 31   0. 40   1. 35  
revenue high:  25. 65 M 2. 70 B 8. 76 B
revenue avg:  8. 88 M 2. 64 B 8. 62 B
revenue low:  2. 50 M 2. 58 B 8. 45 B
return on assets:  -30. 80 % -3. 43 % 4. 51 %
return on equity:  -96. 78 % -104. 30 % 140. 44 %
revenue growth:  85. 00 % 295. 25 % 78. 55 %
revenue/share:  0. 34   12. 50   51. 58  

beta (1yr vs S&P500):  1. 54   1. 27   0. 91  
sharpe (1yr):  -0. 39   0. 20   0. 80  

held % insiders:  6. 28 % 6. 63 % 3. 46 %
held % institutions:  37. 49 % 76. 45 % 67. 87 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-22 : INO
.    101.391 =       101.391 :: --> INITIAL WEIGHT <--
.    - 0.997 =       100.394 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.847 =        285.87 :: P/E factor
.    x 2.209 =       631.475 :: PE/G factor
.    x 1.397 =       882.134 :: beta factor
.    x 0.777 =       685.705 :: sharpe factor
.     x 2.82 =      1933.593 :: current ratio factor
.    x 1.123 =      2172.103 :: quick ratio factor
.    x 1.063 =      2308.845 :: short ratio factor
.    x 2.088 =      4820.025 :: revenue growth factor
.    x 1.119 =      5394.371 :: EV/R factor
.    x 1.041 =      5617.889 :: price-to-book factor
.    x 0.773 =      4344.808 :: debt-to-revenue factor
.    x 1.139 =      4947.129 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.759 =     13650.291 :: sector+industry 1-year gains factor
.     x 1.01 =      13786.59 :: industry 12-weeks return factor
.    x 1.309 =     18051.698 :: industry 2-weeks return factor
.    x 0.953 =     17210.893 :: "drift" penalty 2 days ago
.    x 0.989 =     17015.649 :: "drift" penalty 3 days ago
.    / 2.047 =      8312.063 :: overall "drift" factor
.    x 0.634 =      5266.103 :: largest single-day jump factor
.     x 0.07 =        366.72 :: low price factor
.    x 0.516 =        189.19 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.941 =       178.009 :: forward EPS factor
.    x 0.979 =       174.186 :: forward P/E factor
.    x 1.184 =        206.23 :: industry recommendation factor
.    x 2.844 =       586.577 :: company recommendation factor
.    x 1.002 =       587.468 :: factor historical industry gain for week 29
.    x 1.393 =       818.582 :: target low factor
.    x 1.228 =      1005.125 :: target mean factor
.    x 1.051 =      1056.522 :: target high factor
.    x 5.083 =      5369.841 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =          8.56 :: reduced for readability
.   + 11.054 =        19.614 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     19.614 :: FINAL WEIGHT for NASDAQ:INO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org